G., Faught, E., Knowlton, R., Morawetz, R
10.3390/molecules27238432 68 FakharianF.ThirugnanamS.WelshD
Although current evidence supports broad applicability across BMI, diabetes status, and fibrosis stages F2-F3, subgroup analyses suggest attenuated responses in non-obese patients and in certain ethnic groups (Hispanic patients in ESSENCE), emphasizing the need for precision medicine approaches incorporating anthropometric, genetic (e.g., PNPLA3, HSD17B13), and metabolic profiling
Discard if cloudy or showing particulate matter
During your first appointment, you can expect: Personalized Consultation You will meet with a provider to discuss: Your health history Weight loss goals Previous diet and exercise experiences Current challenges and concerns Treatment preferences Health and Body Composition Assessment We evaluate important metabolic and health factors that may affect weight loss and treatment planning